M&T Bank
LAB icon

M&T Bank’s Standard BioTools LAB Stock Holding History

M&T Bank’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,643
Closed -$21.7K – 1821
2026
Q1 		$21.7K Sell
23,643
-265
-1% -$321 ﹤0.01% 1691
2025
Q4 		$30.6K Buy
+23,908
New +$32.1K ﹤0.01% 1670
2015
Q4 		– Sell
-26,175
Closed -$212K – 1808
2015
Q3 		$212K Buy
26,175
+8,965
+52% +$141K ﹤0.01% 1502
2015
Q2 		$416K Buy
+17,210
New +$543K ﹤0.01% 1316

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

M&T Bank's LAB Position: Q2 2026 in Review

M&T Bank sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 23,643 shares — an estimated $21.7K sold.

M&T Bank first reported a position in LAB in Q2 2015 and held it in 4 quarters. The position peaked at $416K in Q2 2015. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • M&T Bank reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • M&T Bank sold 23,643 Standard BioTools shares in Q2 2026, an estimated $21.7K.
  • M&T Bank first reported a position in Standard BioTools in Q2 2015 and held it in 4 quarters.
  • M&T Bank's Standard BioTools position peaked at $416K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.